![Thomas Meyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Meyer
Directeur Général chez ALTAMIRA THERAPEUTICS LTD.
Fortune : 30 600 $ au 31/05/2024
Profil
Thomas Meyer is the founder of Auris Medical AG, founded in 2003, where he holds the title of Chairman & Chief Executive Officer.
He is also the founder of Auris Medical Holding AG, founded in 1998, where he held the title of Chairman & Chief Executive Officer.
Additionally, he is the founder of Altamira Therapeutics Ltd., founded in 2003, where he holds the title of Chairman & Chief Executive Officer.
Dr. Meyer's current job(s) include being the Chairman of Zilentin AG, Chairman of Pharmatrail Ltd., Managing Director of Altamira Pharma GmbH, and Managing Director of Altamira Medica AG.
Dr. Meyer's former job includes being the Chief Executive Officer & Director of Disetronic Holding AG from 2000 to 2002.
Dr. Meyer obtained a doctorate degree from the University of Fribourg.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
29/03/2024 | 20 000 ( 0,89% ) | 30 600 $ | 31/05/2024 |
Postes actifs de Thomas Meyer
Sociétés | Poste | Début |
---|---|---|
ALTAMIRA THERAPEUTICS LTD. | Directeur Général | 01/04/2003 |
Auris Medical AG
![]() Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Directeur Général | 23/07/2010 |
Altamira Pharma GmbH
![]() Altamira Pharma GmbH Pharmaceuticals: MajorHealth Technology Altamira Pharma GmbH manufactures pharmaceutical products. The private company is based in Zuchwil, Switzerland. The CEO of the Swiss company is Thomas Meyer. | Directeur Général | - |
Zilentin AG
![]() Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Président | - |
Altamira Medica AG
![]() Altamira Medica AG Medical SpecialtiesHealth Technology Part of Altamira Therapeutics Ltd., Altamira Medica AG is a Swiss company that offers bentrio, an OTC drug-free nasal spray designed to protect against airborne allergens and viruses. The company is based in Zug, Switzerland, and Thomas Meyer has been the CEO of the company since 2020. The spray forms a protective gel layer on the nasal mucosa to prevent contact with allergens or virus particles and helps to bind and discharge them. Altamira Medica strives to empower people to live with confidence and control when it comes to protection against allergens. | Directeur Général | 01/09/2020 |
Pharmatrail Ltd. | Président | 01/01/2020 |
Anciens postes connus de Thomas Meyer
Sociétés | Poste | Fin |
---|---|---|
Disetronic Holding AG
![]() Disetronic Holding AG Medical SpecialtiesHealth Technology Disetronic Holding AG manufactured medical products for treatment of diabetes. The company infusion business was integrated into the Roche Diabetes Care Business Area within the Roche Diagnostics Division. Founded in 1990, the company was headquartered in Burgdorf, Switzerland. | Directeur Général | 01/10/2002 |
Auris Medical Holding AG /Old/
![]() Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Directeur Général | - |
Formation de Thomas Meyer
University of Fribourg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ALTAMIRA THERAPEUTICS LTD. | Health Technology |
Entreprise privées | 7 |
---|---|
Auris Medical AG
![]() Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Health Technology |
Disetronic Holding AG
![]() Disetronic Holding AG Medical SpecialtiesHealth Technology Disetronic Holding AG manufactured medical products for treatment of diabetes. The company infusion business was integrated into the Roche Diabetes Care Business Area within the Roche Diagnostics Division. Founded in 1990, the company was headquartered in Burgdorf, Switzerland. | Health Technology |
Auris Medical Holding AG /Old/
![]() Auris Medical Holding AG /Old/ Medical SpecialtiesHealth Technology Auris Medical Holding AG engages in the research, development, and commercialization of pharmaceutical products for inner ear disorders. Its products portfolio targets to treat tinnitus, Menière's disease, and hearing loss. The company was founded by Thomas Meyer on April 1, 1998 and is headquartered in Zug, Switzerland. | Health Technology |
Altamira Pharma GmbH
![]() Altamira Pharma GmbH Pharmaceuticals: MajorHealth Technology Altamira Pharma GmbH manufactures pharmaceutical products. The private company is based in Zuchwil, Switzerland. The CEO of the Swiss company is Thomas Meyer. | Health Technology |
Zilentin AG
![]() Zilentin AG Pharmaceuticals: MajorHealth Technology Zilentin AG develops projects for the treatment of tinnitus and hearing loss. The company is headquartered in Zug, Switzerland. | Health Technology |
Altamira Medica AG
![]() Altamira Medica AG Medical SpecialtiesHealth Technology Part of Altamira Therapeutics Ltd., Altamira Medica AG is a Swiss company that offers bentrio, an OTC drug-free nasal spray designed to protect against airborne allergens and viruses. The company is based in Zug, Switzerland, and Thomas Meyer has been the CEO of the company since 2020. The spray forms a protective gel layer on the nasal mucosa to prevent contact with allergens or virus particles and helps to bind and discharge them. Altamira Medica strives to empower people to live with confidence and control when it comes to protection against allergens. | Health Technology |
Pharmatrail Ltd. |